LMCG Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,771
| Closed | -$932K | – | 263 |
|
|
2024
Q2 | $932K | Sell |
6,771
-31
| -0.5% | -$4.27K | 0.05% | 195 |
|
|
2024
Q1 | $938K | Sell |
6,802
-2,625
| -28% | -$362K | 0.06% | 207 |
|
|
2023
Q4 | $1.24M | Hold |
9,427
| – | – | 0.08% | 204 |
|
|
2023
Q3 | $1.06M | Buy |
9,427
+193
| +2% | +$21.7K | 0.07% | 202 |
|
|
2023
Q2 | $871K | Hold |
9,234
| – | – | 0.06% | 224 |
|
|
2023
Q1 | $935K | Buy |
9,234
+198
| +2% | +$20K | 0.06% | 213 |
|
|
2022
Q4 | $1.08M | Buy |
9,036
+17
| +0.2% | +$2.03K | 0.08% | 206 |
|
|
2022
Q3 | $958K | Buy |
9,019
+11
| +0.1% | +$1.17K | 0.07% | 226 |
|
|
2022
Q2 | $878K | Hold |
9,008
| – | – | 0.06% | 232 |
|
|
2022
Q1 | $845K | Buy |
+9,008
| New | +$845K | 0.05% | 242 |
|
|
2015
Q3 | $6.77M | Buy |
170,154
+23,470
| +16% | +$934K | 0.15% | 263 |
|
|
2015
Q2 | $7.01M | Buy |
146,684
+3,149
| +2% | +$150K | 0.15% | 262 |
|
|
2015
Q1 | $5.7M | Buy |
+143,535
| New | +$5.7M | 0.12% | 291 |
|